151 related articles for article (PubMed ID: 34869643)
1. Rivaroxaban Suppresses Atherosclerosis by Inhibiting FXa-Induced Macrophage M1 Polarization-Mediated Phenotypic Conversion of Vascular Smooth Muscle Cells.
Ma Y; Zhang Y; Qiu C; He C; He T; Shi S; Liu Z
Front Cardiovasc Med; 2021; 8():739212. PubMed ID: 34869643
[No Abstract] [Full Text] [Related]
2. Advanced Glycation End Products Induce Atherosclerosis via RAGE/TLR4 Signaling Mediated-M1 Macrophage Polarization-Dependent Vascular Smooth Muscle Cell Phenotypic Conversion.
Xing Y; Pan S; Zhu L; Cui Q; Tang Z; Liu Z; Liu F
Oxid Med Cell Longev; 2022; 2022():9763377. PubMed ID: 35069982
[TBL] [Abstract][Full Text] [Related]
3. Matrine blocks AGEs- induced HCSMCs phenotypic conversion via suppressing Dll4-Notch pathway.
Liu Z; Wang Y; Zhu H; Qiu C; Guan G; Wang J; Guo Y
Eur J Pharmacol; 2018 Sep; 835():126-131. PubMed ID: 30063915
[TBL] [Abstract][Full Text] [Related]
4. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.
Posthuma JJ; Posma JJN; van Oerle R; Leenders P; van Gorp RH; Jaminon AMG; Mackman N; Heitmeier S; Schurgers LJ; Ten Cate H; Spronk HMH
Sci Rep; 2019 Mar; 9(1):3909. PubMed ID: 30846818
[TBL] [Abstract][Full Text] [Related]
5. Akt1 isoform modulates phenotypic conversion of vascular smooth muscle cells.
Yun SJ; Ha JM; Kim EK; Kim YW; Jin SY; Lee DH; Song SH; Kim CD; Shin HK; Bae SS
Biochim Biophys Acta; 2014 Nov; 1842(11):2184-92. PubMed ID: 25201081
[TBL] [Abstract][Full Text] [Related]
6. Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.
Pham PT; Fukuda D; Yagi S; Kusunose K; Yamada H; Soeki T; Shimabukuro M; Sata M
Sci Rep; 2019 Aug; 9(1):11206. PubMed ID: 31371788
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
[TBL] [Abstract][Full Text] [Related]
8. CTRP9 induces macrophages polarization into M1 phenotype through activating JNK pathway and enhances VSMCs apoptosis in macrophages and VSMCs co-culture system.
Chen JY; Song CX; Lei SY; Li J; Zuo AJ; Xu D; Guo Y
Exp Cell Res; 2020 Oct; 395(1):112194. PubMed ID: 32712018
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Eur J Pharmacol; 2018 Feb; 820():222-228. PubMed ID: 29269019
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia inducible factor 1α in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment.
Qi D; Wei M; Jiao S; Song Y; Wang X; Xie G; Taranto J; Liu Y; Duan Y; Yu B; Li H; Shah YM; Xu Q; Du J; Gonzalez FJ; Qu A
Cell Death Dis; 2019 Jul; 10(8):544. PubMed ID: 31320613
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling triggered via the ligand DLL4 impedes M2 macrophage differentiation and promotes their apoptosis.
Pagie S; Gérard N; Charreau B
Cell Commun Signal; 2018 Jan; 16(1):4. PubMed ID: 29321062
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development: Implications for the Treatment of Vein Graft Failure.
Koga JI; Nakano T; Dahlman JE; Figueiredo JL; Zhang H; Decano J; Khan OF; Niida T; Iwata H; Aster JC; Yagita H; Anderson DG; Ozaki CK; Aikawa M
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2343-2353. PubMed ID: 26404485
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban Suppresses the Progression of Ischemic Cardiomyopathy in a Murine Model of Diet-Induced Myocardial Infarction.
Liu J; Nishida M; Inui H; Chang J; Zhu Y; Kanno K; Matsuda H; Sairyo M; Okada T; Nakaoka H; Ohama T; Masuda D; Koseki M; Yamashita S; Sakata Y
J Atheroscler Thromb; 2019 Oct; 26(10):915-930. PubMed ID: 30867376
[TBL] [Abstract][Full Text] [Related]
14. The Increase of pFAK and THBS1 Protein and Gene Expression Levels in Vascular Smooth Muscle Cells by Histamine-treated M1 Macrophages.
Khosravi M; Najafi M; Amirfarhangi A; Karimi M; Fattahi F; Shabani M
Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):72-79. PubMed ID: 30848575
[TBL] [Abstract][Full Text] [Related]
15. Local Production of Activated Factor X in Atherosclerotic Plaque Induced Vascular Smooth Muscle Cell Senescence.
Sanada F; Muratsu J; Otsu R; Shimizu H; Koibuchi N; Uchida K; Taniyama Y; Yoshimura S; Rakugi H; Morishita R
Sci Rep; 2017 Dec; 7(1):17172. PubMed ID: 29215061
[TBL] [Abstract][Full Text] [Related]
16. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban, a Direct Oral Factor Xa Inhibitor, Attenuates Atherosclerosis by Alleviating Factor Xa-PAR2-Mediated Autophagy Suppression.
Ito Y; Maejima Y; Nakagama S; Shiheido-Watanabe Y; Tamura N; Sasano T
JACC Basic Transl Sci; 2021 Dec; 6(12):964-980. PubMed ID: 35024502
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of Protease-Activated Receptor 2 Promotes Proliferation and Migration of Human Vascular Smooth Muscle Cells (VSMCs).
Wei M; Liu Y; Zheng M; Wang L; Ma F; Qi Y; Liu G
Med Sci Monit; 2019 Nov; 25():8854-8862. PubMed ID: 31756174
[TBL] [Abstract][Full Text] [Related]
19. Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin.
Meng Q; Yu X; Chen Q; Wu X; Kong X; Wang S; Cai D; Cheng P; Li Y; Bian H
J Ethnopharmacol; 2020 Jan; 246():112207. PubMed ID: 31476440
[TBL] [Abstract][Full Text] [Related]
20. PAR2 promotes M1 macrophage polarization and inflammation via FOXO1 pathway.
Chen L; Gao B; Zhang Y; Lu H; Li X; Pan L; Yin L; Zhi X
J Cell Biochem; 2019 Jun; 120(6):9799-9809. PubMed ID: 30552714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
